Earnings
Negative
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring
Breaking news from global financial markets
2 months ago
Read More
2 months ago
3,756
Editas Medicine Inc (NASDAQ:EDIT) Reports Mixed Q2 2025 Earnings: Revenue Beat but Wider Loss
Earnings
2 months ago
4,294
2 months ago
4,434
2 months ago
897
2 months ago
2,732
2 months ago
3,582
2 months ago
3,238
2 months ago
3,270
2 months ago
803
2 months ago
4,034
2 months ago
3,002
Annovis Bio (NYSE:ANVS) Reports Narrower Q2 2025 Loss, Advances Alzheimer's and Parkinson's Trials
Earnings
2 months ago
682
2 months ago
1,889
2 months ago
1,621
2 months ago
3,011
Trending Now
1
Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty...
20,771
31 minutes ago
2
VFC DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages V.F. Corporation Investor...
43,009
32 minutes ago
3
Lee Enterprises Announces Intent to Pursue Rights Offering to Potentially Reduce...
8,409
33 minutes ago
4
LyondellBasell prices public offering of guaranteed notes
32,906
33 minutes ago
5
Mink Ventures Grants Stock Options
38,581
36 minutes ago